Clinical Trial Update: Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) [Phase 1]

View source ↗

Summary

This Phase 1 bioequivalence study evaluated a fixed-dose combination tablet containing saxagliptin 5 mg and metformin XR 500 mg against taking saxagliptin 5 mg …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Kombiglyze XR (Saxagliptin/metformin XR)
• Saxagliptin (saxagliptin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2011-05-17